BETTER HEALTH FOR LESS MONEY

We educate, motivate and empower consumers of prescription drugs to save money.

Our Solution

Our Solution

For Employers

Let the team at Rx Savings Solutions use their cost-saving methods to engage, educate and empower your employees to become wise consumers of prescription drugs. This benefit not only helps your employees save money, but greatly reduces your costs as well!

For Employees

There’s no hiding the fact that overall healthcare spending is on the rise, and prescription drugs are no exception. The Centers for Medicare and Medicaid Services projects that annual expenditures for prescription drugs could increase by 86% from 2011 to 2020.

As pharmacists we recognized
the need for a solution to increasing
healthcare costs and proved we can create extraordinary savings for our members.

Michael Rea, PharmD
founder and ceo

The problem with prescription pricing

Prescription drug expenses are rising at alarming rates and make up a large portion of benefit-related expenses for employers. According to Kaiser Permanente, medication-related costs increased an average of 11% annually from 1996-2008. Most employers are not equipped to effectively manage this expense on their own. Rx Savings Solutions is a company advocating for employers and incented to align with them to address this problem together.

Our bright idea

Rx Savings Solutions was established in 2008 with one goal in mind – to educate, motivate and empower consumers of prescription drugs to save money. This continues to be a focus of our service; however, the company simultaneously focuses on saving payers, namely self-insured employers, money as well. In fact, historical data has shown employers save an average of 5-6 times what their employees experience.

Savings through analysis

We use a patented software platform to deliver our solution to employers and their covered members. By using our service to educate employees on savings opportunities, employers can rely on their employees to make the right choice thus saving both parties money. Rx Savings Solutions supports a collaborative approach where employers offer our consumerism solution in order to deliver proper information to their employees, which ultimately leads to savings for everyone.

Our mission

To engage and empower consumers of healthcare by providing them with information they have a right to know.

Executive Team

    Michael Rea, PharmD

    / Founder and CEO

    Dr. Rea founded Rx Savings Solutions in 2008 after routinely witnessing consumers struggling to pay for their medications. He noticed quickly at that time that consumers were paying much more than they needed to, which was attributable to a lack of information available to them. He set out on his mission to arm consumers with this information and add efficiency and transparency back in to the world of pharmacy. Dr. Rea has been involved with research surrounding pharmacy transparency for over 10 years. He received his Doctor of Pharmacy degree from Creighton University.

    Douglas Besch, PharmD, MBA

    / Chief Operating Officer

    Dr. Besch has substantial experience working as both a transparency researcher and in retail pharmacy. He is the acting Chief Operating Officer and leads the Rx Savings Solutions team with day-to-day operations. Dr. Besch holds a doctor of pharmacy degree from the Creighton University School of Pharmacy and Health Professions and a master's degree in business administration from the Creighton University College of Business.

    Drew Komenda

    / Chief Revenue Officer

    Drew Komenda is a high performing veteran of the healthcare industry and a proven entrepreneurial leader. Drew spent more than a decade negotiating, consulting and working alongside physicians, hospital systems, group purchasing organizations and integrated delivery networks for Johnson & Johnson. Drew has a deep understanding of the business and substantive delivery of healthcare.

    Shahryar Qadri

    / Chief Technology Officer

    Shahryar Qadri is a seasoned health information technology leader. Shahryar spent 11 years at Cerner in a variety of engineering and managerial roles including developing data warehouses, implementing business intelligence strategies, designing systems for real-time eligibility and claims adjudication, creating a Third Party Administrator organization and leading edge development for on-site health centers, wellness programs and provider networks. Shahryar received his undergraduate and graduate education in computer science from Creighton University.

    Brandy Rea

    / Chief Legal Counsel

    Brandy Rea has a wealth of experience in corporate law, including facilitating mergers and acquisitions, negotiating complex contractual arrangements, and assisting in corporate governance and management. Before joining Rx Savings Solutions, Ms. Rea specialized in providing her legal expertise to entities in the health care industry, including to pharmacies and pharmacy benefit managers. Ms. Rea not only advised such clients on corporate legal matters but also assisted health care entity clients in navigating through complex health care laws and regulations. Ms. Rea graduated from Creighton University School of Law, magna cum laude.

Our Clients

Latest News

Rx Savings Solutions on Bloomberg Radio

Pimm Fox and Kathleen Hays had Michael Rea, CEO of Rx Savings Solutions, on the show to participate and weigh in regarding the rising costs of prescription drugs and notably, the congressional hearings that filled headline news that week.

  • February 4, 2016

Price of Valeant drug singled out by Clinton rose 356% in a year

Valeant increased the price of the drug in question, called dihydroergotamine or DHE 45, on four separate occasions between July 2014 and July 2015, according to figures compiled by RX Savings for the Financial Times.

"Increases of this size are unsustainable," said Michael Rea, chief executive of RX Savings, which sells software to employers to help them cut the cost of buying medicines for workers.

  • February 2, 2016

Valeant says it's backing away from its most controversial practice - a week before congressional hearings begin

Valeant Pharmaceuticals has repeated a pledge to back off its practice of hiking the price of off-patent drugs, a week before congressional hearings on the issue begin.

In an op-ed article on CNBC.com on Wednesday, interim CEO Howard Schiller and interim chairman Robert Ingram said the company would start cutting prices on some drugs.

  • January 21, 2016

Contact Us

Have a question? Want to know more? Send us a message.